Cyclin D1 (CCND1), a key cell cycle regulatory protein that governs the cell cycle progression from G1 to S phase, can promote cell proliferation or induce growth arrest and apoptosis. Since the identification of a well-characterized functional polymorphism, G870A in exon 4 of CCND1, several molecular epidemiological studies were conducted in recent years to evaluate the association between G870A and breast cancer risk in diverse populations. However, the results remain conflicting rather than conclusive. This meta-analysis on 5,371 cases with breast cancer and 5,336 controls from 7 published case-control studies showed that the variant allele 870A was associated with a significantly increased risk of breast cancer (AA vs. GG: OR = 1.18, 95% CI = 1.06–1.32; AG vs. GG: OR = 1.12, 95% CI = 1.01–1.23; AA/AG vs. GG: OR = 1.14, 95% CI = 1.04–1.25) without any between-study heterogeneity. In the stratified analysis by race, we found that the increased breast cancer risk associated with G870A polymorphism was more evident in Caucasians (OR = 1.14, 95% CI = 1.01–1.28, P = 0.88 for heterogeneity test), but not significant in Asians (OR = 1.10, 95% CI = 0.85–1.42, P = 0.05 for heterogeneity test). The results suggest that CCND1 G870A polymorphism may contribute to breast cancer development, especially in Caucasians. Additional well-designed large studies were required for the validation of this association in different populations.
CCND1Polymorphism Breast Cancer Meta-analysis
This is a preview of subscription content, log in to check access.
This work was supported in part by Program for Chang jiang Scholars and Innovative Research Team in University and the Innovative Key Grant of Ministry of Education of China (#705023).
Cook SJ, Balmanno K, Garner A, Millar T, Taverner C, Todd D (2000) Regulation of cell cycle re-entry by growth, survival and stress signalling pathways. Biochem Soc Trans 28(2):233–240PubMedGoogle Scholar
Hosokawa Y, Arnold A (1998) Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer 22(1):66–71. doi :10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9<3.0.CO;2-5PubMedCrossRefGoogle Scholar
Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z et al (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278(32):30339–30347. Erratum in: J Biol Chem 2004 Jul 16; 279. 29:30914. doi:10.1074/jbc.M303969200Google Scholar
Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H et al (1998) Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16(13):1701–1712. doi:10.1038/sj.onc.1201691PubMedCrossRefGoogle Scholar
Grieu F, Malaney S, Ward R, Joseph D, Iacopetta B (2003) Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res 23(5b):4257–4259PubMedGoogle Scholar
Shu XO, Moore DB, Cai Q, Cheng J, Wen W, Pierce L et al (2005) Association of cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev 14(1):91–97PubMedGoogle Scholar
Ceschi M, Sun CL, Van Den Berg D, Koh WP, Yu MC, Probst-Hensch N (2005) The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis 26(8):1457–1464. doi:10.1093/carcin/bgi093PubMedCrossRefGoogle Scholar
Zhang J, Li Y, Wang R, Wen D, Sarbia M, Kuang G et al (2003) Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 105(2):281–284. doi:10.1002/ijc.11067PubMedCrossRefGoogle Scholar
Wang L, Habuchi T, Mitsumori K, Li Z, Kamoto T, Kinoshita H et al (2003) Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism. Int J Cancer 103(1):116–120. doi:10.1002/ijc.10793PubMedCrossRefGoogle Scholar
Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS et al (2001) Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis 22(8):1195–1199. doi:10.1093/carcin/22.8.1195PubMedCrossRefGoogle Scholar
Tan XL, Nieters A, Kropp S, Hoffmeister M, Brenner H, Chang-Claude J (2008) The association of cyclin D1 G870A and E-cadherin C-160A polymorphisms with the risk of colorectal cancer in a case control study and meta-analysis. Int J Cancer 122(11):2573–2580. doi:10.1002/ijc.23363PubMedCrossRefGoogle Scholar
Lewis RC, Bostick RM, Xie D, Deng Z, Wargovich MJ, Fina MF et al (2003) Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 63(23):8549–8553PubMedGoogle Scholar